25 XP   0   0   10

Verastem Inc
Buy, Hold or Sell?

Let's analyse Verastem together

PenkeI guess you are interested in Verastem Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Verastem Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Verastem Inc

I send you an email if I find something interesting about Verastem Inc.

Quick analysis of Verastem (30 sec.)










What can you expect buying and holding a share of Verastem? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$3.10
Expected worth in 1 year
$8.03
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$4.92
Return On Investment
52.5%

For what price can you sell your share?

Current Price per Share
$9.38
Expected price per share
$5.94 - $10.86
How sure are you?
50%

1. Valuation of Verastem (5 min.)




Live pricePrice per Share (EOD)

$9.38

Intrinsic Value Per Share

$-47.65 - $-17.68

Total Value Per Share

$-44.54 - $-14.57

2. Growth of Verastem (5 min.)




Is Verastem growing?

Current yearPrevious yearGrowGrow %
How rich?$78.5m$47.3m$31.1m39.7%

How much money is Verastem making?

Current yearPrevious yearGrowGrow %
Making money-$87.3m-$73.8m-$13.5m-15.5%
Net Profit Margin0.0%-2,844.7%--

How much money comes from the company's main activities?

3. Financial Health of Verastem (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#417 / 1010

Most Revenue
#822 / 1010

Most Profit
#705 / 1010

Most Efficient
#262 / 1010

What can you expect buying and holding a share of Verastem? (5 min.)

Welcome investor! Verastem's management wants to use your money to grow the business. In return you get a share of Verastem.

What can you expect buying and holding a share of Verastem?

First you should know what it really means to hold a share of Verastem. And how you can make/lose money.

Speculation

The Price per Share of Verastem is $9.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Verastem.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Verastem, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.10. Based on the TTM, the Book Value Change Per Share is $1.23 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.59 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Verastem.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-3.45-36.8%-3.45-36.8%-2.92-31.1%-3.55-37.9%-2.91-31.1%
Usd Book Value Change Per Share1.2313.1%1.2313.1%-1.59-16.9%-0.36-3.9%-0.15-1.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.2313.1%1.2313.1%-1.59-16.9%-0.36-3.9%-0.15-1.6%
Usd Price Per Share8.14-8.14-0.40-2.81-3.26-
Price to Earnings Ratio-2.36--2.36--0.14--0.85--1.25-
Price-to-Total Gains Ratio6.61-6.61--0.25-0.94--0.49-
Price to Book Ratio2.62-2.62-0.21-1.72-1.41-
Price-to-Total Gains Ratio6.61-6.61--0.25-0.94--0.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.38
Number of shares106
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.23-0.36
Usd Total Gains Per Share1.23-0.36
Gains per Quarter (106 shares)130.50-38.34
Gains per Year (106 shares)522.00-153.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105225120-153-163
20104410340-307-316
30156615560-460-469
40208820780-614-622
50261026000-767-775
60313231220-921-928
70365436440-1074-1081
80417641660-1227-1234
90469846880-1381-1387
100522052101-1534-1540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.07.00.046.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%1.00.012.07.7%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.07.00.046.2%

Fundamentals of Verastem

About Verastem Inc

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is involved in cell proliferation, migration, transformation, and survival of tumor cells; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors. The company is involved in clinical studies, including RAMP 301, a randomized global confirmatory trial to evaluate the combination of Avutometinib and Defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer; RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of Avutometinib and in combination with Defactinib; and FRAME, an investigation of Avutometinib and Defactinib in patients with KRAS mutant cancers and subsequent analyses; and RAMP 204 and 205. It has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing Avutometinib; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic, and prophylactic uses in humans. In addition, it has a clinical collaboration agreement with Amgen, Inc. to evaluate the combination of Avutometinib with Amgen's KRAS-G12C inhibitor LUMAKRAS which in Phase 1/2 trial entitled RAMP 203; and a discovery and development collaboration with GenFleet Therapeutics to advance new programs targeting RAS pathway-driven cancers. Verastem, Inc. was incorporated in 2010 and is headquartered in Needham, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-12 21:52:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Verastem Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Verastem earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Verastem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,844.7%+2,844.7%
TTM-5Y-1,568.1%+1,568.1%
5Y-1,568.1%10Y-811.2%-757.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--218.5%+218.5%
YOY-2,844.7%-284.8%-2,559.9%
5Y-1,568.1%-435.1%-1,133.0%
10Y-811.2%-589.3%-221.9%
1.1.2. Return on Assets

Shows how efficient Verastem is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • -58.4% Return on Assets means that Verastem generated $-0.58 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Verastem Inc:

  • The MRQ is -58.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.4%TTM-58.4%0.0%
TTM-58.4%YOY-77.7%+19.3%
TTM-58.4%5Y-74.2%+15.9%
5Y-74.2%10Y-62.2%-12.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.4%-13.2%-45.2%
TTM-58.4%-12.7%-45.7%
YOY-77.7%-11.5%-66.2%
5Y-74.2%-13.8%-60.4%
10Y-62.2%-15.5%-46.7%
1.1.3. Return on Equity

Shows how efficient Verastem is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • -111.2% Return on Equity means Verastem generated $-1.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Verastem Inc:

  • The MRQ is -111.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -111.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-111.2%TTM-111.2%0.0%
TTM-111.2%YOY-155.8%+44.6%
TTM-111.2%5Y-555.3%+444.1%
5Y-555.3%10Y-311.9%-243.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-111.2%-16.8%-94.4%
TTM-111.2%-16.0%-95.2%
YOY-155.8%-14.8%-141.0%
5Y-555.3%-19.3%-536.0%
10Y-311.9%-20.0%-291.9%

1.2. Operating Efficiency of Verastem Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Verastem is operating .

  • Measures how much profit Verastem makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Verastem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,809.6%+2,809.6%
TTM-5Y-1,322.9%+1,322.9%
5Y-1,322.9%10Y-696.0%-627.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.8%+299.8%
TTM--239.2%+239.2%
YOY-2,809.6%-295.4%-2,514.2%
5Y-1,322.9%-485.9%-837.0%
10Y-696.0%-624.6%-71.4%
1.2.2. Operating Ratio

Measures how efficient Verastem is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Verastem Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY29.141-29.141
TTM-5Y14.059-14.059
5Y14.05910Y7.484+6.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.238-3.238
TTM-3.313-3.313
YOY29.1413.838+25.303
5Y14.0595.675+8.384
10Y7.4847.612-0.128

1.3. Liquidity of Verastem Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Verastem is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.45 means the company has $5.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Verastem Inc:

  • The MRQ is 5.447. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.447. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.447TTM5.4470.000
TTM5.447YOY4.287+1.160
TTM5.4475Y5.349+0.098
5Y5.34910Y6.749-1.401
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4473.870+1.577
TTM5.4474.173+1.274
YOY4.2875.332-1.045
5Y5.3496.126-0.777
10Y6.7496.448+0.301
1.3.2. Quick Ratio

Measures if Verastem is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Quick Ratio of 7.48 means the company can pay off $7.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Verastem Inc:

  • The MRQ is 7.480. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.480. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.480TTM7.4800.000
TTM7.480YOY4.657+2.823
TTM7.4805Y7.612-0.132
5Y7.61210Y10.136-2.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4803.510+3.970
TTM7.4803.994+3.486
YOY4.6575.357-0.700
5Y7.6126.105+1.507
10Y10.1366.404+3.732

1.4. Solvency of Verastem Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Verastem assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Verastem to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.48 means that Verastem assets are financed with 47.5% credit (debt) and the remaining percentage (100% - 47.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Verastem Inc:

  • The MRQ is 0.475. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.475. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.475TTM0.4750.000
TTM0.475YOY0.501-0.026
TTM0.4755Y0.475+0.001
5Y0.47510Y0.361+0.114
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4750.339+0.136
TTM0.4750.336+0.139
YOY0.5010.271+0.230
5Y0.4750.368+0.107
10Y0.3610.388-0.027
1.4.2. Debt to Equity Ratio

Measures if Verastem is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Debt to Equity ratio of 90.6% means that company has $0.91 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Verastem Inc:

  • The MRQ is 0.906. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.906. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.906TTM0.9060.000
TTM0.906YOY1.006-0.099
TTM0.9065Y4.342-3.436
5Y4.34210Y2.387+1.955
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9060.390+0.516
TTM0.9060.402+0.504
YOY1.0060.339+0.667
5Y4.3420.428+3.914
10Y2.3870.461+1.926

2. Market Valuation of Verastem Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Verastem generates.

  • Above 15 is considered overpriced but always compare Verastem to the Biotechnology industry mean.
  • A PE ratio of -2.36 means the investor is paying $-2.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Verastem Inc:

  • The EOD is -2.716. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.357. Based on the earnings, the company is expensive. -2
  • The TTM is -2.357. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.716MRQ-2.357-0.359
MRQ-2.357TTM-2.3570.000
TTM-2.357YOY-0.138-2.219
TTM-2.3575Y-0.849-1.508
5Y-0.84910Y-1.249+0.400
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.716-2.296-0.420
MRQ-2.357-2.600+0.243
TTM-2.357-2.726+0.369
YOY-0.138-4.145+4.007
5Y-0.849-6.259+5.410
10Y-1.249-6.348+5.099
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Verastem Inc:

  • The EOD is -2.745. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.382. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.382. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.745MRQ-2.382-0.363
MRQ-2.382TTM-2.3820.000
TTM-2.382YOY-0.160-2.222
TTM-2.3825Y-1.072-1.310
5Y-1.07210Y-1.545+0.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.745-2.937+0.192
MRQ-2.382-3.326+0.944
TTM-2.382-3.553+1.171
YOY-0.160-5.605+5.445
5Y-1.072-8.385+7.313
10Y-1.545-8.882+7.337
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Verastem is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.62 means the investor is paying $2.62 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Verastem Inc:

  • The EOD is 3.021. Based on the equity, the company is fair priced.
  • The MRQ is 2.622. Based on the equity, the company is underpriced. +1
  • The TTM is 2.622. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.021MRQ2.622+0.399
MRQ2.622TTM2.6220.000
TTM2.622YOY0.215+2.407
TTM2.6225Y1.724+0.898
5Y1.72410Y1.411+0.314
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0211.909+1.112
MRQ2.6222.114+0.508
TTM2.6222.096+0.526
YOY0.2152.884-2.669
5Y1.7243.554-1.830
10Y1.4113.938-2.527
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Verastem Inc.

3.1. Institutions holding Verastem Inc

Institutions are holding 66.794% of the shares of Verastem Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Viking Global Investors LP9.71040.0732245629200
2023-09-30Bvf Inc6.66210.3695168521900
2023-12-31Vivo Capital, LLC6.0821.0254153846100
2023-09-30Deerfield Management Co6.0820.2756153846100
2023-12-31Orbimed Advisors, LLC6.0450.2486152911500
2023-12-31Soleus Capital Management, L.P.5.63591.28761425634782655.8087
2023-12-31Adage Capital Partners Gp LLC5.13930.0219130000000
2023-12-31Vanguard Group Inc4.54730.0002115025300
2023-09-30Citadel Advisors Llc3.53340.0016893785-35655-3.8362
2023-09-30TANG CAPITAL MANAGEMENT LLC3.52441.0227891514-248486-21.797
2023-12-31BlackRock Inc1.29080.0001326512242178.011
2023-12-31Longwood Capital Partners LLC0.91811.064223224922490.9778
2023-12-31Geode Capital Management, LLC0.91770.0002232128122135.5535
2023-12-31Opaleye Management Inc0.83570.457621140000
2023-12-31Sectoral Asset Management Inc0.80380.712720332700
2023-12-31Vontobel Holding Ltd.0.80380.008320332700
2023-12-31Susquehanna International Group, LLP0.64170.0003162312140042628.837
2023-12-31Jefferies Financial Group Inc0.63070.008515954100
2023-12-31AlphaCentric Advisors, LLC0.5930.819615000000
2023-12-31Morgan Stanley - Brokerage Accounts0.56770.00011436001324611189.1642
Total 64.96487.397916433130+105306+0.6%

3.2. Funds holding Verastem Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.99230.000675692500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.42560.004436060800
2023-12-31AlphaCentric LifeSci Healthcare I0.5931.171415000000
2024-02-29Fidelity Extended Market Index0.51430.0042130100-630-0.4819
2023-09-30BlackRock Extended Mkt Composite0.22690.0033573892651985.9054
2024-03-31BlackRock Extended Equity Market K0.1980.004150085180.036
2024-02-29Fidelity Total Market Index0.16670.00064216000
2024-02-29Fidelity Series Total Market Index0.12460.00063151700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08920.00292257500
2023-12-31Northern Trust Extended Eq Market Idx0.08160.00292063900
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08160.00292063900
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.08020.000520279-453250-95.7175
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.08020.00082027900
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07170.002918131340.1879
2024-02-29Vanguard Balanced Index Inv0.06630.00041678000
2024-02-29Spartan Total Market Index Pool E0.0570.00061440700
2024-02-29Fidelity Nasdaq Composite Index0.05610.0011141877705.739
2024-03-29Avantis US Small Cap Equity ETF0.04880.01451234500
2023-12-31CornerCap Fundametrics Small0.04670.07231181000
2023-12-31CornerCap Small-Cap Value Advisor0.04670.07241181000
Total 7.04751.36341782665-426539-23.9%

3.3. Insider Transactions

Insiders are holding 0.547% of the shares of Verastem Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-05Daniel CalkinsSELL610.87
2024-03-25Daniel CalkinsSELL2512.02
2024-03-20Daniel CalkinsSELL5511.07
2024-03-18Dan PatersonSELL24410.71
2024-03-18Robert E GagnonSELL28310.71
2024-01-12Robert E GagnonSELL920410.95
2024-01-05Daniel CalkinsSELL68.5
2023-12-26Daniel CalkinsSELL258.08
2023-12-20Daniel CalkinsSELL577.93
2023-12-18Dan PatersonSELL2447.64
2023-12-18Robert E GagnonSELL2847.64
2023-10-05Daniel CalkinsSELL57.3
2023-09-25Daniel CalkinsSELL259.4
2023-09-21Daniel CalkinsSELL2329.31
2023-09-18Dan PatersonSELL2409.91
2023-09-18Robert E GagnonSELL2789.91
2023-07-06Daniel CalkinsSELL58.02
2023-06-26Daniel CalkinsSELL268.17
2023-06-20Brian M StuglikSELL27510.3
2023-06-20Dan PatersonSELL18310.3

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Verastem Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.2311.2310%-1.588+229%-0.362+129%-0.154+112%
Book Value Per Share--3.1053.1050%1.873+66%2.656+17%3.089+0%
Current Ratio--5.4475.4470%4.287+27%5.349+2%6.749-19%
Debt To Asset Ratio--0.4750.4750%0.501-5%0.475+0%0.361+32%
Debt To Equity Ratio--0.9060.9060%1.006-10%4.342-79%2.387-62%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---3.454-3.4540%-2.918-16%-3.553+3%-2.914-16%
Free Cash Flow Per Share---3.418-3.4180%-2.517-26%-2.972-13%-2.553-25%
Free Cash Flow To Equity Per Share--1.8871.8870%-0.470+125%-0.916+149%0.043+4277%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---17.678--------
Intrinsic Value_10Y_min---47.647--------
Intrinsic Value_1Y_max---2.390--------
Intrinsic Value_1Y_min---3.462--------
Intrinsic Value_3Y_max---6.710--------
Intrinsic Value_3Y_min---11.599--------
Intrinsic Value_5Y_max---10.461--------
Intrinsic Value_5Y_min---20.989--------
Market Cap237271790.000+13%205905370.000205905370.0000%10181438.750+1922%71143593.750+189%82494949.375+150%
Net Profit Margin----0%-28.4470%-15.6810%-8.1120%
Operating Margin----0%-28.0960%-13.2290%-6.9600%
Operating Ratio----0%29.141-100%14.059-100%7.484-100%
Pb Ratio3.021+13%2.6222.6220%0.215+1120%1.724+52%1.411+86%
Pe Ratio-2.716-15%-2.357-2.3570%-0.138-94%-0.849-64%-1.249-47%
Price Per Share9.380+13%8.1408.1400%0.403+1922%2.813+189%3.261+150%
Price To Free Cash Flow Ratio-2.745-15%-2.382-2.3820%-0.160-93%-1.072-55%-1.545-35%
Price To Total Gains Ratio7.619+13%6.6126.6120%-0.253+104%0.939+604%-0.491+107%
Quick Ratio--7.4807.4800%4.657+61%7.612-2%10.136-26%
Return On Assets---0.584-0.5840%-0.777+33%-0.742+27%-0.622+7%
Return On Equity---1.112-1.1120%-1.558+40%-5.553+399%-3.119+180%
Total Gains Per Share--1.2311.2310%-1.588+229%-0.362+129%-0.154+112%
Usd Book Value--78533000.00078533000.0000%47391000.000+66%67186200.000+17%78144600.000+0%
Usd Book Value Change Per Share--1.2311.2310%-1.588+229%-0.362+129%-0.154+112%
Usd Book Value Per Share--3.1053.1050%1.873+66%2.656+17%3.089+0%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---3.454-3.4540%-2.918-16%-3.553+3%-2.914-16%
Usd Free Cash Flow---86453000.000-86453000.0000%-63673000.000-26%-75177600.000-13%-64584400.000-25%
Usd Free Cash Flow Per Share---3.418-3.4180%-2.517-26%-2.972-13%-2.553-25%
Usd Free Cash Flow To Equity Per Share--1.8871.8870%-0.470+125%-0.916+149%0.043+4277%
Usd Market Cap237271790.000+13%205905370.000205905370.0000%10181438.750+1922%71143593.750+189%82494949.375+150%
Usd Price Per Share9.380+13%8.1408.1400%0.403+1922%2.813+189%3.261+150%
Usd Profit---87367000.000-87367000.0000%-73848000.000-15%-95843400.000+10%-76712300.000-12%
Usd Revenue----0%2596000.000-100%22124200.000-100%13733900.000-100%
Usd Total Gains Per Share--1.2311.2310%-1.588+229%-0.362+129%-0.154+112%
 EOD+6 -2MRQTTM+0 -0YOY+22 -95Y+23 -1010Y+19 -14

4.2. Fundamental Score

Let's check the fundamental score of Verastem Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.716
Price to Book Ratio (EOD)Between0-13.021
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.480
Current Ratio (MRQ)Greater than15.447
Debt to Asset Ratio (MRQ)Less than10.475
Debt to Equity Ratio (MRQ)Less than10.906
Return on Equity (MRQ)Greater than0.15-1.112
Return on Assets (MRQ)Greater than0.05-0.584
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Verastem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5031.488
Ma 20Greater thanMa 5010.809
Ma 50Greater thanMa 10011.494
Ma 100Greater thanMa 20010.679
OpenGreater thanClose9.230
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Gross Profit  14,64940,12254,771-52,9241,8476312,478-2,540-62
Net Interest Income  -16,227948-15,2795,488-9,7918,869-9222,2931,371
Total Other Income Expense Net -16,868-1,304-18,1728,381-9,7918,916-8755,5924,717



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets149,718
Total Liabilities71,185
Total Stockholder Equity78,533
 As reported
Total Liabilities 71,185
Total Stockholder Equity+ 78,533
Total Assets = 149,718

Assets

Total Assets149,718
Total Current Assets143,682
Long-term Assets6,036
Total Current Assets
Cash And Cash Equivalents 78,835
Short-term Investments 59,220
Net Receivables 42
Other Current Assets 5,585
Total Current Assets  (as reported)143,682
Total Current Assets  (calculated)143,682
+/-0
Long-term Assets
Property Plant Equipment 1,208
Long-term Assets Other 4,587
Long-term Assets  (as reported)6,036
Long-term Assets  (calculated)5,795
+/- 241

Liabilities & Shareholders' Equity

Total Current Liabilities26,380
Long-term Liabilities44,805
Total Stockholder Equity78,533
Total Current Liabilities
Short-term Debt 941
Accounts payable 7,184
Other Current Liabilities 17,928
Total Current Liabilities  (as reported)26,380
Total Current Liabilities  (calculated)26,053
+/- 327
Long-term Liabilities
Long term Debt 40,086
Capital Lease Obligations 1,471
Long-term Liabilities  (as reported)44,805
Long-term Liabilities  (calculated)41,557
+/- 3,248
Total Stockholder Equity
Common Stock3
Retained Earnings -824,890
Accumulated Other Comprehensive Income 13
Other Stockholders Equity 882,248
Total Stockholder Equity (as reported)78,533
Total Stockholder Equity (calculated)57,374
+/- 21,159
Other
Capital Stock3
Cash and Short Term Investments 138,055
Common Stock Shares Outstanding 22,054
Current Deferred Revenue327
Liabilities and Stockholders Equity 149,718
Net Debt -37,278
Net Invested Capital 97,460
Net Working Capital 117,302
Property Plant and Equipment Gross 2,800
Short Long Term Debt Total 41,557



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
3,604
59,037
92,923
125,261
98,649
113,094
83,629
89,791
277,236
145,046
154,349
108,662
95,050
149,718
149,71895,050108,662154,349145,046277,23689,79183,629113,09498,649125,26192,92359,0373,604
   > Total Current Assets 
0
47,941
57,082
101,955
95,316
110,843
81,295
87,787
253,259
84,961
144,938
105,740
92,870
143,682
143,68292,870105,740144,93884,961253,25987,78781,295110,84395,316101,95557,08247,9410
       Cash And Cash Equivalents 
3,584
20,954
10,096
18,889
33,901
110,258
32,349
82,176
129,867
43,514
67,782
100,256
74,933
78,835
78,83574,933100,25667,78243,514129,86782,17632,349110,25833,90118,88910,09620,9543,584
       Short-term Investments 
0
26,857
46,480
82,423
58,774
85,388
48,548
4,496
119,786
31,992
73,444
79,004
12,961
59,220
59,22012,96179,00473,44431,992119,7864,49648,54885,38858,77482,42346,48026,8570
       Net Receivables 
0
0
161
123
2,348
154
204
0
306
2,524
239
516
31
42
42315162392,52430602041542,34812316100
       Inventory 
0
0
0
0
0
-154
0
0
327
3,096
0
-100,772
0
0
00-100,77203,09632700-15400000
   > Long-term Assets 
0
11,096
35,841
23,306
3,333
2,251
2,334
2,004
23,977
60,085
9,411
2,922
2,180
6,036
6,0362,1802,9229,41160,08523,9772,0042,3342,2513,33323,30635,84111,0960
       Property Plant Equipment 
8
709
811
631
2,825
2,048
1,417
861
1,369
4,024
3,142
210
1,881
1,208
1,2081,8812103,1424,0241,3698611,4172,0482,8256318117098
       Long Term Investments 
0
0
34,944
22,344
0
0
0
0
0
0
5,995
0
0
0
0005,99500000022,34434,94400
       Intangible Assets 
0
0
0
0
0
0
0
0
21,577
20,008
0
0
0
0
000020,00821,57700000000
       Other Assets 
0
1,393
86
331
508
203
917
1,143
1,031
36,053
8,995
410
299
0
02994108,99536,0531,0311,143917203508331861,3930
> Total Liabilities 
368
71,803
2,457
7,815
9,883
10,625
11,332
32,107
152,937
137,872
39,075
21,103
47,659
71,185
71,18547,65921,10339,075137,872152,93732,10711,33210,6259,8837,8152,45771,803368
   > Total Current Liabilities 
368
3,146
2,399
7,804
9,204
10,040
10,991
17,128
37,077
29,890
17,093
18,590
21,663
26,380
26,38021,66318,59017,09329,89037,07717,12810,99110,0409,2047,8042,3993,146368
       Short-term Debt 
0
0
0
0
0
0
0
14,828
5,716
420
558
667
1,069
941
9411,0696675584205,71614,8280000000
       Short Long Term Debt 
0
0
0
0
0
0
0
14,828
5,716
0
0
0
275
0
02750005,71614,8280000000
       Accounts payable 
279
2,273
1,848
2,760
3,216
3,942
4,095
9,186
10,253
9,655
1,875
2,302
4,901
7,184
7,1844,9012,3021,8759,65510,2539,1864,0953,9423,2162,7601,8482,273279
       Other Current Liabilities 
89
873
551
5,044
5,988
6,098
6,896
7,942
21,108
450
14,660
15,621
14,983
17,928
17,92814,98315,62114,66045021,1087,9426,8966,0985,9885,04455187389
   > Long-term Liabilities 
0
68,657
58
11
679
585
341
14,979
115,860
107,982
21,982
2,513
25,996
44,805
44,80525,9962,51321,982107,982115,86014,979341585679115868,6570
       Long term Debt Total 
0
0
0
0
0
0
0
14,828
114,737
103,623
19,051
249
24,526
0
024,52624919,051103,623114,73714,8280000000
       Other Liabilities 
0
516
58
11
679
516
341
151
1,123
870
0
0
0
0
00008701,12315134151667911585160
       Deferred Long Term Liability 
0
0
38
0
0
0
0
0
0
0
0
0
0
0
000000000003800
> Total Stockholder Equity
3,236
-12,766
90,466
117,446
88,766
102,469
72,297
57,684
124,299
7,174
115,274
87,559
47,391
78,533
78,53347,39187,559115,2747,174124,29957,68472,297102,46988,766117,44690,466-12,7663,236
   Common Stock
1
1
2
3
3
4
4
5
7
8
17
19
20
3
32019178754433211
   Retained Earnings Total Equity0-737,523-663,711-592,511-524,785-375,576-303,142-235,323-198,883-141,018-87,653-46,45100
   Accumulated Other Comprehensive Income 
0
-14,469
22
28
11
43
29
-2
127
14
53
34
0
13
130345314127-22943112822-14,4690
   Capital Surplus 
0
0
136,893
205,068
229,770
301,305
307,587
360,823
499,741
531,937
707,715
751,217
784,894
0
0784,894751,217707,715531,937499,741360,823307,587301,305229,770205,068136,89300
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
-51,972
43,970
205,068
229,770
301,305
307,587
360,823
499,741
531,937
707,715
751,217
784,894
882,248
882,248784,894751,217707,715531,937499,741360,823307,587301,305229,770205,06843,970-51,9720



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-62
Gross Profit-62-62
 
Operating Income (+$)
Gross Profit-62
Operating Expense-92,022
Operating Income-92,084-92,084
 
Operating Expense (+$)
Research Development61,356
Selling General Administrative28,197
Selling And Marketing Expenses0
Operating Expense92,02289,553
 
Net Interest Income (+$)
Interest Income5,114
Interest Expense-4,139
Other Finance Cost-396
Net Interest Income1,371
 
Pretax Income (+$)
Operating Income-92,084
Net Interest Income1,371
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-87,367-96,801
EBIT - interestExpense = -96,223
-87,367
-83,228
Interest Expense4,139
Earnings Before Interest and Taxes (EBIT)-92,084-83,228
Earnings Before Interest and Taxes (EBITDA)-92,022
 
After tax Income (+$)
Income Before Tax-87,367
Tax Provision-0
Net Income From Continuing Ops-76,807-87,367
Net Income-87,367
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses92,084
Total Other Income/Expenses Net4,717-1,371
 

Technical Analysis of Verastem
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Verastem. The general trend of Verastem is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Verastem's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Verastem Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.78 < 9.81 < 10.86.

The bearish price targets are: 8.9999 > 6.98 > 5.94.

Tweet this
Verastem Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Verastem Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Verastem Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Verastem Inc. The current macd is -0.61074461.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Verastem price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Verastem. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Verastem price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Verastem Inc Daily Moving Average Convergence/Divergence (MACD) ChartVerastem Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Verastem Inc. The current adx is 19.93.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Verastem shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Verastem Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Verastem Inc. The current sar is 11.72.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Verastem Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Verastem Inc. The current rsi is 31.49. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Verastem Inc Daily Relative Strength Index (RSI) ChartVerastem Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Verastem Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Verastem price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Verastem Inc Daily Stochastic Oscillator ChartVerastem Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Verastem Inc. The current cci is -122.43815302.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Verastem Inc Daily Commodity Channel Index (CCI) ChartVerastem Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Verastem Inc. The current cmo is -48.1548862.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Verastem Inc Daily Chande Momentum Oscillator (CMO) ChartVerastem Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Verastem Inc. The current willr is -89.16408669.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Verastem Inc Daily Williams %R ChartVerastem Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Verastem Inc.

Verastem Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Verastem Inc. The current atr is 0.59367407.

Verastem Inc Daily Average True Range (ATR) ChartVerastem Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Verastem Inc. The current obv is 8,617,219.

Verastem Inc Daily On-Balance Volume (OBV) ChartVerastem Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Verastem Inc. The current mfi is 26.90.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Verastem Inc Daily Money Flow Index (MFI) ChartVerastem Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Verastem Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Verastem Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Verastem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5031.488
Ma 20Greater thanMa 5010.809
Ma 50Greater thanMa 10011.494
Ma 100Greater thanMa 20010.679
OpenGreater thanClose9.230
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Verastem with someone you think should read this too:
  • Are you bullish or bearish on Verastem? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Verastem? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Verastem Inc

I send you an email if I find something interesting about Verastem Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Verastem Inc.

Receive notifications about Verastem Inc in your mailbox!